Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2301studies shown
Showing 673-684 of 2,301
Behavioral study icon
Active Not RecruitingNCT04541563

Fisher Wallace Neurostimulation & Depression Study

This study is looking at whether Fisher Wallace Cranial Electrotherapy Stimulator Device can help people with depression. Participants take part in Fisher Wallace Cranial Electrotherapy Stimulator Device and complete follow-up assessments.

Remote / online
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralOver 21 Years
Countries
United States
Sponsor
ProofPilot
Condition
Depression
Drug study icon
Active Not RecruitingNCT03573349

Ketamine Associated ACC GABA and Glutamate Change and Depression Remission:

This study is looking at whether Ketamine can help people with depression, Treatment Resistant Depression, or Depression in bipolarity. Participants take part in Ketamine and complete follow-up assessments.

In United States
Why is this study shown?

This study is directly about Depression.

Depression, BipolarityDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States
Sponsor
Mayo Clinic
Condition
Depression, Bipolarity
Behavioral study icon
Active Not RecruitingNCT06399406

Mindfulness Engaged Neurostimulation for Depression

This study is looking at whether a digital support tool can help people with Depression or Treatment Resistant Depression. Participants receive a study treatment and complete follow-up visits and assessments.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of California, San Diego
Condition
Depression
Drug study icon
CompletedNCT05531591

RCT of Brain Longitudinal Biomarker Study (OPT-Neuro RCT)

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugOver 60 Years
Countries
United States, Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Depression
Drug study icon
CompletedNCT03185819

3 Fixed Doses of Intranasal Esketamine for depression

This study is completed in the United States, in France, in Belgium, .... It is testing 3 Fixed Doses of Intranasal Esketamine for depression.

In United States
Why is this study shown?

This study is directly about Depression.

Depression, SuicidalityDrugFrom 9 Years to 17 Years
Countries
United States, France, Belgium, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression, Suicidality
Drug study icon
TerminatedNCT02882711

The UTHealth Ketamine Project

This study exists to explore whether ketamine treatment could improve care and understanding. Researchers are trying to understand whether ketamine treatment can improve attention, thinking, or day-to-day functioning.

In United States
Why is this study shown?

This study is directly about Depression.

Depression, BipolarityDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
The University of Texas Health Science Center, Houston
Condition
Depression, Bipolarity
Drug study icon
CompletedNCT03586427

Zelquistinel in the Treatment of Major Depressive Disorder

This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Syndeio Biosciences, Inc
Condition
Depression
Drug study icon
CompletedNCT02417064

Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant for treatment-resistant depression

This study is completed in the United States, in France, in Canada, .... It is testing efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant for treatment-resistant depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 64 Years
Countries
United States, France, Canada, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
CompletedNCT02418585

Efficacy, Safety, and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant for treatment-resistant depression

This study is completed in the United States, in Czechia, in Germany, .... It is testing efficacy, Safety, and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant for treatment-resistant depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 64 Years
Countries
United States, Czechia, Germany, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Device study icon
CompletedNCT03680781

Accelerated Theta Burst in Treatment-Resistant Depression: A Dose Finding and Biomarker Study

This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand what a therapy or guided support program can reveal about signals in the brain or body that may guide care later on.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 75 Years
Countries
United States
Sponsor
Stanford University
Condition
Depression
Device study icon
Active Not RecruitingNCT07147218

Accelerated TMS for MDD

This study is looking at care and outcomes for people with depression. Taking part may give some people access to TMS, but direct benefit is not guaranteed.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDeviceOver 15 Years
Countries
United States
Sponsor
Neuronetics
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.